EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mRNA-engineered T cells against telomerase: a novel immunotherapy approach for cancer

Mudasir Maqbool, Zulfkar Qadrie, Amita Joshi Rana, Sumel Ashique, Md Sadique Hussain

EXCLI Journal · 28.05.2025 · 24 · 570-572

DOI: 10.17179/excli2025-8327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EXCLI Journal, online erschienen am 28.05.2025. Verfasst von Mudasir Maqbool und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Maqbool, M., Qadrie, Z., Rana, A. J., Ashique, S., & Hussain, M. S. (2025). mRNA-engineered T cells against telomerase: a novel immunotherapy approach for cancer. EXCLI Journal, 24, 570-572. https://doi.org/10.17179/excli2025-8327

Vancouver

Maqbool M, Qadrie Z, Rana AJ, Ashique S, Hussain MS. mRNA-engineered T cells against telomerase: a novel immunotherapy approach for cancer. EXCLI Journal. 2025;24:570-572. doi:10.17179/excli2025-8327

BibTeX
@article{Maqbool2025,
  author = {Maqbool, Mudasir and Qadrie, Zulfkar and Rana, Amita Joshi and Ashique, Sumel and Hussain, Md Sadique},
  title = {mRNA-engineered T cells against telomerase: a novel immunotherapy approach for cancer},
  journal = {EXCLI Journal},
  year = {2025},
  volume = {24},
  pages = {570--572},
  doi = {10.17179/excli2025-8327}
}
Kostenlos starten →